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G.J. Glade,1 A.C. Vahl,1* W. Wisselink,2 M.A.M. Linsen2 and R. Balm3Departments of 1Surgery, Onze Lieve Vrouwe Gasthuis, 2Vascular Surgery, Vrije Universiteit Medical Center,
and 3Vascular Surgery, Academic Medical Center, Amsterdam, The NetherlandsObjectives. To evaluate the results of open surgery or endovascular stent graft repair of descending thoracic aortic
aneurysm (TAA).
Design, materials and methods. This is a retrospective multicenter study of 95 patients undergoing TAA repair (42 stent
grafts, 53 open repair). The median age was 67 years. Post-operative complications, mid-term survival and costs were
assessed. The results were pooled with data in the literature.
Results. After a mean follow up of 26 months (open group) and 15 months (endovascular group) survival was similar for
patients treated by either repair method. Post-operative pneumonia was more in the open group (p!0.02). The hospital costs
of open treatment were 40% more than that of the endovascular procedure. Combining the present results with pooled data
from the literature the peri-operative mortality and paraplegia rate was less in the endovascular group (p!0.05).
Conclusions. These retrospective data suggest that endografting of descending thoracic aneurysms can be performed with
less peri-operative morbidity, at lower hospital costs, but with equal mid-term life expectancy, compared with open grafting.Keywords: Thoracic; Descending; Aneurysm; Endovascular; Grafting; Mortality; Survival; Paraplegia; Costs.Introduction
Open ‘conventional’ surgical repair of descending
thoracic aortic aneurysms is still considered to be the
standard reference treatment. However, this operation
is associated with significant peri-operative morbidity
and mortality. In large series mortality rates of 5.5–
8.8% and paraplegia rates of 2.7–14.3% have been
reported.1–6.
Endovascular thoracic stent graft repair offers the
theoretical advantage of a minimal invasive operation
combined with a short aortic occlusion time. In 1997
the first large series of 44 patients were reported in
which aneurysms were repaired using home made
stent grafts. Outcome was favourable with a mortality
rate of 6.8% and a paraplegia rate of 4.3%.7 To date
there are no randomised trials available comparing
open and endovascular repair of descending thoracic
aneurysms.ing author. Dr. A.C. Vahl, Department of Surgery, Onze
e Gasthuis, P.O. Box 95500, 1090 HM Amsterdam, The
: a.c.vahl@olvg.nl
0028 + 07 $35.00/0 q 2004 Elsevier Ltd. All rights reserThe present study was performed to evaluate the
survival and treatment costs of all patients treated for a
descending thoracic aortic aneurysm by either open
surgery (OPEN) or endovascular stent graft repair
(ENDO) in three vascular centres in Amsterdam.Materials and Methods
Medical records of all consecutive patients operated
between January 1997 and April 2003 for a descending
thoracic aneurysm in three hospitals. (Academic
Medical Center (AMC), Vrije Universiteit Medical
Center (VUMC) and Onze Lieve Vrouwe Gasthuis
(OLVG)) were reviewed. All consecutive patients with
elective presentations with a chronic fusiform or
saccular aneurysm of the descending aorta were
included. Patients with trauma, aortoenteric fistulas,
type B dissection or an acute ruptured aneurysm were
excluded.
In 1997 all patients were treated by open repair.
Endovascular treatment was introduced in January
1999 and from the year 2001 on this technique has been
first choice treatment in the three vascular centres.Eur J Vasc Endovasc Surg 29, 28–34 (2005)
doi:10.1016/j.ejvs.2004.10.003, available online at http://www.sciencedirect.com onved.
Thoracic Aneurysm 29Operative technique
Transthoracic aneurysm repair
Open surgery was performed by a left lateral
thoracotomy and graft replacement of the descending
aorta. Atriofemoral shunting was used by surgeon
preference and availability. CSF drainage was used
routinely.8
Endovascular repair
Vascular access for the endovascular treatment was
obtained through surgical exposure of the common
femoral artery or common iliac artery in case of an
external iliac artery diameter of less than 8 mm. A five
French pigtail catheter was positioned in the ascend-
ing aorta, to be changed by a 0.035 in. diameter back-
up Meier guide wire (Boston Scientific-Schneider,
Bu¨lach, Switzerland). In selected patients an
additional angiography catheter was inserted in the
ascending aorta through the right brachial artery.
Angiography was performed before and after stent
graft deployment. If necessary, balloon dilatation of
the proximal and distal anchoring zones further
expanded the stent grafts. Three types of stent graft
have been used: the AneuRxe thoracic stent graft
(Medtronic AVE, CA, USA) in 1 patient, the Goree
thoracic aortic graft in (WL Gore and Associates, AZ,
USA) in 17 patients and the talente thoracic endo-
prosthesis (Medtronic AVE, CA, USA) in 24 patients.
These two groups were compared in a case-control
study with regard to post-operative complications and
mid-term survival. Post-operatively patients were
followed by 6 (endovascular group) or 12 monthly
(open group) CT-scans. Survival was assessed by
review of patients’ notes since when a patient died
during follow up a note, extracted from the registrar’s
office, is made in the file. Pooled data for post-
operative paraplegia and mortality from the literature
were then compared to our results.
The mean costs of the diagnostic process, the
operative procedure, the costs of implants and
adjunctive procedures were calculated for each patient
from the mean outcome values of the study-cohort.
Statistical analysis was performed using univariate
analysis (c2-test and Fisher’s exact test when necess-
ary) for pre- and post-operative variables. Multivariate
Cox regression analysis was used to identify the
independent predictors of survival. Several possible
factors were analysed which might influence the
survival in a step-wise model. Factors that were
associated with a change of more than 10% in the
regression coefficient were left in the model for
identification of independent predictive factors of
survival. Odds ratios (OR) and 95% confidenceintervals were calculated in univariate analysis for
pre- and post-operative parameters. The hazard ratio
(HR) was calculated for predictive factors of survival
in the multivariate model. A p-value of less than 0.05
was considered statistically significant. Analysis was
done in SPSS version 11.0.Results
Between January 1997 and April 2003, 95 consecutive
(59 males, 36 females) patients with a mean age of 67
years (range 39–81 years; no statistically significant
differences between the open and endovascular
group) were operated on for a descending thoracic
aneurysm. Sixteen patients were operated non-elec-
tively (recent onset of pain or contained rupture): 9 in
the open group and 7 in the endovascular group. The
mean diameter of the aneurysm was 65 mm (range 45–
90 mm) in the open group and 61 mm (range 40–
80 mm) in the endovascular group. All aneurysms
commenced at least 1 cm distal to the subclavian
artery and there was at least 3 cm of non-dilated aorta
proximal to the celiac trunk.
Patient characteristics and pre-operative risk factors
are listed in Table 1. Fifty-three patients underwent
open surgical repair (AMC nZ20, VUMC nZ21,
OLVG nZ12), 42 patients were treated with stent
grafts (AMC nZ18, VUMC nZ9, OLVG nZ15). A
mean of 2.1 endografts (range 1–4) per patient were
implanted. The pre-operative risk factors were not
statistically different between groups.
The mean anaesthesia time (300 vs. 160 min; p!
0.0001), in hospital time (30 vs. 10 days; p!0.0001) and
mean length of stay on the intensive care (11 vs. 14
days; p!0.0001) was statistically significant different,
in favour of the endovascular group. Blood loss was
also less in the endovascular group, but too many
missing values prohibited calculation of significance.
There was no difference in post-operative morbidity
between the two groups, except that pneumonia
appeared significantly more in the open group (29
vs. 9%, odds ratio 0.3, 95% confidence interval 0.08–
0.8; p!0.02) (Table 2).
Reoperations during the same admission were
performed in 13 patients in the open group. The
reasons for reinterventions were: post-operative bleed-
ing (nZ11), duodenal perforation (nZ1) and persist-
ent thoracic duct leakage (nZ1). There were 5 early
reinterventions in the endovascular group due to post-
operative bleeding at access site in one patient, type I
endoleak in 2 patients requiring additional stent graft
implantation and paraplegia in 1 patient in whom an
emergency open procedure was performed.9Eur J Vasc Endovasc Surg Vol 29, January 2005
Table 1. Pre-operative risk factors of patients (percentage of patients in each group) with a descending thoracic aneurysm; open:
treatment by thoracotomy and graft replacement of the aorta, endo: groin incision and endografting
Open N Open percentage
(%)
Endo N Endo percentage
(%)
p-value
Hypertension 40 75 36 86 0.21
Smoking/COPD 43 81 25 60 0.38
Diabetes 3 6 5 12 0.31
Angina pectoris 6 11 9 21 0.20
Previous myocardial infarction 8 15 10 25 0.30
CABG in history 4 8 7 17 0.23
Renal failure 7 13 6 14 0.70
TIA/CVA/carotid surgery in history 5 9 8 19 0.23
G. J. Glade et al.30During follow up one reoperation in the open group
was performed after 1.5 years because of a false
aneurysm. In the endovascular group 2 late reopera-
tions were performed: 1 patient with a type I endoleak
after 6 months, which was converted to an open
procedure and 1 patient had a contained perforation
caused by a bare stent after 4.5 months which was
treated by an additional endovascular graft.
Paraplegia was less in the endovascular group, but
this was not statistically significant (8 vs. 2%, odds
ratio 0.3; 95% confidence interval 0.03–2.7; pZ0.24). Of
14 patients in the open group that were operated on
without distal perfusion three developed paraplegia rate
vs. only one case of paraplegia in 39 patients operated
with distal perfusion (p!0.01, univariate analysis).
There was no statistical significant difference in
hospital mortality between both treatment groups: 6
patients (12%) in the open group vs. 2 patients (5%) in
the endovascular group (pZ0.23, odds ratio 1.4; 95%
confidence interval 0.7–2.6).
Survival after a mean follow up of 26 months (range
3–82 months) in the open group and a mean follow up
of 15 months (range 1–48 months) in the endovascular
group did not show a significant difference (Fig. 1).
The proportion of survivors was 92% after 1 year and
73% after 3 years. Five years survival was 58%,
however, there were only patients with open repair
left for this analysis.
Several factors, which might influence the mid-termTable 2. Post-operative morbidity (percentage of the patients in each
(univariate analysis)
Open N Open percentage
(%)
End
Mortality 6 11 2
Reoperation 15 28 8
Post-op. bleeding 9 17 2
Pneumonia 15 28 4
Myocardial infarction 2 4 1
TIA/CVA 2 4 0
Paraplegia 4 8 1
Intestinal ischaemia 0 0 2
Renal failure 6 11 1
Eur J Vasc Endovasc Surg Vol 29, January 2005survival, were investigated in a prediction model by
means of Cox regression analysis, including pre-
operative factors (cardiac failure, renal failure, acute
aneurysm, diameter of the aneurysm and smoking)
and post-operative factors (reoperation rate, occur-
rence of pneumonia, paraplegia, cardiac or intestinal
ischaemia, time of anaesthesia, intensive care stay and
hospital admission).
None of these factors proved to be significantly
associated with the mid-term survival in either
treatment group. In Table 3 a multivariate model is
shown of the factors which gave a more than 10%
change of the regression coefficient in the multivariate
model, which might indicate possible bias.
When the incidences of paraplegia of recent studies
mainly consisting of patients treated for a thoracic
descending aneurysm are pooled, the incidence of
paraplegia is 6.1% in 604 patients with an open
procedure and 2.4% in 544 patients with an endovas-
cular procedure: p!0.01.1,3–7,10–16 The absolute differ-
ence is 3.7% (95% confidence interval 1.3–6.0%)
resulting in a number needed to treat (NNT) with an
endograft of 27 patients (95% confidence interval 17–
76) to prevent 1 case of paraplegia.
The post-operative hospital mortality rate in these
studies is 10.9% in open procedures compared to 7.0%
in patients with a stent graft: p!0.05. The absolute
difference is 3.9% (95% confidence interval 0.6–6.0%):
NNTZ26 (95% confidence interval 17–166) (Table 4).group) in patients operated for a descending thoracic aneurysm
o N Endo percentage
(%)
p-value Odds ratio (95%
confidence interval)
5 0.33 1.4 (0.7–2.6)
19 0.25 0.6 (0.2–1.5)
5 0.10 0.2 (0.05–1.1)
9 0.02 0.3 (0.08–0.8)
2 0.66 0.6 (0.05–6.7)
0 0.50 0.5 (0.4–1.7)
2 0.24 0.3 (0.03–2.7)
5 0.12 0.5 (0.4–1.6)
2 0.12 0.2 (0.02–1.6)
Fig. 1. Proportion of survival of patients with a open procedure (grey line), compared to patients with an endovascular
procedure (black line).
Thoracic Aneurysm 31In Table 5 the hospital costs of both treatments are
calculated. The mean hospital costs per patient
operated by endografting is 20,663 vs. 33,770 euros,
for a patient operated by an open procedure.Discussion
The main outcome of the present study is that the mid-
term survival for patients operated for a descending
thoracic aneurysm, after 3 years, is equal for both the
open and endovascular technique. There were no pre-
or post-operative factors, which could independently
predict survival. Only four peri- and post-operative
parameters could be identified in univariate analysis
to be statistically significant in favour of the endovas-
cularly treated group: operation time, duration of
hospital admission, duration of intensive care stay,
incidence of pneumonia.
In multivariate analysis these factors, as well as
other potential confounders, were not independently
predictive of a more favourable mid-term probability
of survival. These figures must be interpreted withTable 3. Multivariate analysis model of potential confounders
independently predict survival
Variable Standard error Wald
Age 0.08 2.25
Angina 1.57 0.18
CABG 1.55 0.02
COPD/smoking 1.42 0.03
Pneumonia 1.59 0.04cautious, because the endovascular group had a
shorter mean follow up.
To our knowledge only one other case-control series
is published where these two treatment groups were
compared. Ehrlich reported a series of 68 patients,
with a mean age of 51 years and a mean aneurysm
diameter of 7 cm. Ten patients were treated with an
endovascular graft and 58 patients served as controls.
The 30 day mortality was 10% in the endovascular
group vs. 31% in the open group, the paraplegia rate
was 0 vs. 12%, the mean intensive care stay was 4 vs.
13 days, the mean hospital stay was 6 vs. 10 days and
length of intervention was 150 vs. 320 min.3 Due to the
small numbers the differences in mortality and
paraplegia were not significant. These findings are in
concordance with the results from the present study,
however, no mid-term follow up was reported.
Our mid-term survival is in concordance with
patient series reported in the literature. The following
actuarial survival rates are reported in the literature:
81% (nZ103) after 1 year (10), 73–90% after 2 years
(nZ103)10 (nZ38)13 and 63–82% (nZ44)7 (nZ54)16
after 3 years.and significant factors from univariate analysis which might
p-value Hazard ratio 95% confidence
interval
0.13 0.89 0.77–1.04
0.67 1.95 0.09–42.00
0.89 1.24 0.06–25.89
0.86 1.28 0.08–20.77
0.84 1.37 0.06–30.8
Eur J Vasc Endovasc Surg Vol 29, January 2005
Table 4. Pooled incidence of post-operative paraplegia and mortality of studies presenting cohort series of patients dominantly treated
for a descending thoracic aneurysm
Author Patients open N Patients endo N Paraplegia open
N (%)
Paraplegia endo
N (%)
Mortality open
N (%)
Mortality endo
N (%)
Galloway 1996 78 6 (8) 8 (10)
Semba 1997 44 2 (5) 3 (7)
Ehrlich 1998 58 10 6 (10) 0 (0) 20 (34) 1 (10)
Mitchell 1999 104 3 (3) 9 (9)
Biglioli 1999 143 54 7 (5) 0 (0) 8 (15) 2 (4)
Cooley 2000 132 11 (8) 17 (13)
Greenberg 2000 25 3 (12) 5 (20)
Estrera 2001 193 7 (4) 13 (7)
Criado 2002 74 0 (0) 1 (1)
Bell 2003 67 3 (4) 5 (7)
Bergeron 2003 38 0 (0) 3 (8)
Orend 2003 74 2 (3) 7 (10)
Czerny 2004 54 0 (0) 2 (1)
Total 604 544 37 (6.1) 13 (2.4) 66 (10.9) 38 (7.0)
Paraplegia open vs. endo: c2Z7.5. p!0.01. Mortality open vs. endo: c2Z4.7. p!0.05.
G. J. Glade et al.32It can be concluded that we are dealing with a
patient group with a life expectancy less than that of
the general population of that age. We know from
large series that many patients die of non-aneurysmal
related reasons. Long term follow up seems to be
mandatory for endografts, because of late rupture due
to material fatigue.17 We did not calculate the costs of
follow up for patients with an endograft, however, the
costs of serial CT-scans is just a small percentage of the
hospital costs.
The incidence of reoperations for endoleaks is
reported to be 47% at a mean duration of 3.7 years in
the first generation stents,10 and 4.1–13.5% in second
generation stents, the type of stents used in our
study.14,16 Our incidence of 2/42 is in concordance
with the literature and not different from the incidence
of late reoperations in the open group.
The incidence of paraplegia in patients with a
descending thoracic aneurysm is reported to be ratherTable 5. Costs per patient operated by endovascular or open repair
Endo (V) Open (
Peri-operative
Operation costs.
Including anaes-
thesia time
1333 4000
Prosthesis 10,000 500
Specialists 600 1000
Radiological
investigations
2000 400
Laboratory 200 200
Nursing costs
Intensive care 2310 18,150
Ward 1620 3420
Post-operative
Paraplegia reha-
bilitation
2600 6100
Total 20,663 33,770
Eur J Vasc Endovasc Surg Vol 29, January 2005low, compared to thoracoabdominal surgery, although
it is still significant. The incidence is strongly related to
clamping time. In a multivariate analysis model it has
been concluded that aortic cross clamping is a risk
factor (p!0.008) for the development of paraplegia
with an odds ratio of 1.03/min and for hospital
mortality with an odds ratio of 2.5/min clamping
time. During follow up the survival was reported to be
negatively associated with the occurrence paraplegia
(p!0.05).4
Our paraplegia rate was 2% in the endovascular
group and 8% in the open group. Due to the small
numbers this was not statistically significant, so a type
II error can occur. For this reasons we performed a
small meta-analysis of a cumulative cohort of patients
reported in recent literature, who are treated for a
descending aneurysm by endovascular or open repair.
From this meta-analysis of pooled data of more than
1000 patients it can be concluded that the paraplegiaV) Costs calculation remarks
Endo: V500/h, Open: V800/h. including distal
perfusion and personnel
Two Talent stents/patient Dacron graft for open
Endo: surgeon and radiologist; open surgeon and
cardiothoracic surgeon
Mean stay see text
Mean stay see text
Costs of life long care (rehospitalisation etc.) not
included. Calculation according to percentages in text
Thoracic Aneurysm 33and mortality rate is less for patients treated by
endografting, however, the number needed to treat is
rather high.
Even in studies report on patients who received
stent grafts on a compassionate use base because they
were unfit to undergo open repair the pooled mortality
and paraplegia rate is significantly lower in patients
treated with an endograft. This lower figure will
influence the mean hospital costs of these patients, as
we showed, as well as their life expectancy.
We studied this period of time (1997–2003), because
during this period we changed gradually our policy
from open treatment to endovascular treatment.
Operations were performed by the same surgeons.
Also in this strict period of time other potentially time
dependent biases, like experience of the team, patient
case mix and anaesthetic technique will not be a strong
confounder in statistical analysis. On the contrary we
have the impression that since the introduction of the
endograft our inclusion of compassionate cases has
increased, however, this is not reflected by the patient
characteristics in Table 1.
Mortality and paraplegia rates for open procedures
have been used to create mathematical models to
perform risk analyses for patients with TAA.18–20 Risk
of rupture within 1 year can be estimated by an
equation, where independent risk factors for rupture
(age, pain, COPD, aortic diameter) are included.18
It can be calculated that the operative mortality for
the open procedure is less than rupture risk at
aneurysms with a diameter of more than 6–7 cm.
Patients operated with an endograft, who have a lower
peri-operative mortality, will have a benefit in survival
when operated with an aortic diameter from 5 to 6 cm.
It therefore seems justified to operate on patients with
a descending aortic aneurysm, by endografting, with a
diameter of 5 cm or more at any age. For open
procedures we consider the age of 80 years as
maximum, because of the higher complication rate,
as reported in literature even in selected cases with a
mortality of 25%.21
Successful operations for thoracic aneurysms result
in good quality of life in the mid and long term.22,23
However, similar to endovascular treatment of infra-
renal aneurysms, the quality of life could be impaired
in patients with a stent graft caused by the new
technology and the strict follow up.24 For thoracic
stenting no quality of life studies are available yet.
In this study we have shown that the total peri-
operative costs of a patient treated with an endoproth-
esis is 61% less than for a patient operated by open
repair, despite the higher costs of prosthetic material.
In conclusion, it seems, from this retrospective
analysis, that in our hospital system in Amsterdamendografting of descending thoracic aneurysm can be
performed with less peri-operative morbidity, at lower
hospital costs, but with equal mid-term life expect-
ancy, compared with open grafting. Therefore, when
technically feasible, we consider endografting to be the
preferred procedure for the treatment of patients with
a descending thoracic aneurysm.References
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